R. C. Horns
R. C. Horns publishes mostly in Oncology, Public Health, Environmental and Occupational Health and Genetics, on topics such as Estrogen and related hormone effects, Cancer Treatment and Pharmacology and Economic and Financial Impacts of Cancer.
- World rank
- #2,240,979 of 7,710,434 ranked researchers
- Rank in United States
- #670,787 of 1,627,098
- Works
- 16
- Citations
- 536
- Citations per work
- 33.5
What does R. C. Horns research?
R. C. Horns's work is mostly in Medicine (49%), Biochemistry, Genetics and Molecular Biology (11%), Economics, Econometrics and Finance (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences849.0%
- Medicine849.0%
- Everything else531.0%
- Life Sciences211.1%
- Social Sciences18.9%
- 1Oncology18% of their works
- 2Public Health, Environmental and Occupational Health18% of their works
- 3Genetics11% of their works
- 4Economics and Econometrics9% of their works
- 5Hematology7% of their works
- 6Epidemiology7% of their works
Research topics
- Estrogen and related hormone effects
- Cancer Treatment and Pharmacology
- Economic and Financial Impacts of Cancer
- Menopause: Health Impacts and Treatments
- Multiple and Secondary Primary Cancers
- Acute Myeloid Leukemia Research
- Colorectal Cancer Treatments and Studies
- Clinical practice guidelines implementation
Which keywords describe R. C. Horns's research?
The keywords of their largest research topics: Breast Cancer, Estrogen, Chemotherapy-Induced Peripheral Neuropathy, Cost of Care, Financial Toxicity, Receptor, Signaling and Taxanes.
- Second Primary Neoplasms
- Menopause
- Hormone Therapy
- Clinical Guidelines
- Acute Myeloid Leukemia
- Taxanes
- Receptor
- Cost of Care
- Estrogen
- Breast Cancer
- Chemotherapy-Induced Peripheral Neuropathy
- Financial Toxicity
- Signaling
- AML
- Cetuximab
- Guideline Development
- KRAS Mutations
- Multiple Primary Cancers
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Breast Cancer52 topics
- Estrogen52 topics
- Chemotherapy-Induced Peripheral Neuropathy31 topic
- Cost of Care31 topic
- Financial Toxicity31 topic
- Receptor31 topic
- Signaling31 topic
- Taxanes31 topic
- AML21 topic
- Acute Myeloid Leukemia21 topic
- Cetuximab21 topic
- Clinical Guidelines21 topic
- Guideline Development21 topic
- Hormone Therapy21 topic
- KRAS Mutations21 topic
- Menopause21 topic
- Multiple Primary Cancers21 topic
- Second Primary Neoplasms21 topic
Where does R. C. Horns work?
R. C. Horns's main affiliation in the publication record is Children's Oncology Group, United States.
How many publications and citations does R. C. Horns have?
OpenAlex counts 16 works and 536 citations for R. C. Horns, an h-index of 7, ranking #2,240,979 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about R. C. Horns. Posts are plain text and can be reported.